Sarah James
Stock Analyst at Cantor Fitzgerald
(4.00)
# 1,753
Out of 5,043 analysts
501
Total ratings
54.8%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Upgraded: Buy | $300 → $460 | $431.87 | +6.51% | 40 | Oct 7, 2026 | |
| TEM Tempus AI | Initiated Coverage: Buy | $80 | $70.93 | +12.79% | 1 | Sep 2, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $13 → $5 | $1.58 | +216.46% | 2 | Aug 17, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $21 | $12.67 | +65.75% | 2 | Aug 17, 2026 | |
| SGRY Surgery Partners | Reiterated: Buy | $33 → $18 | $13.89 | +29.59% | 10 | Aug 10, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 | $27.93 | +10.99% | 14 | Aug 6, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $15 | $2.63 | +470.34% | 12 | Aug 5, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Hold | $30 | $29.25 | +2.56% | 17 | Jul 29, 2026 | |
| TDOC Teladoc Health | Reiterated: Buy | $10 | $5.77 | +73.31% | 8 | Jul 29, 2026 | |
| CNC Centene | Reiterated: Buy | $75 | $65.36 | +14.75% | 58 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $194 | $177.35 | +9.39% | 37 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $209 | $196.93 | +6.13% | 42 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 | $263.78 | -7.12% | 29 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $451.09 | +16.38% | 35 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $110 | $86.16 | +27.67% | 23 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $450 | $412.70 | +9.04% | 29 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.3382 | +787.05% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.77 | +69.49% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $340 | $282.43 | +20.38% | 28 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.5378 | +1,201.60% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.67 | +71.31% | 1 | Feb 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 | $379.30 | +16.00% | 45 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $28 | $19.78 | n/a | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $9.10 | n/a | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $5 | $12.25 | n/a | 3 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128 → $103 | $179.25 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $57 | $37.55 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $56 → $76 | $123.33 | n/a | 13 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $0.3579 | n/a | 1 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $80 | $84.01 | n/a | 7 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $2.76 | n/a | 12 | Aug 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $290 | $423.96 | n/a | 1 | Oct 19, 2017 |
Humana
Oct 7, 2026
Upgraded: Buy
Price Target: $300 → $460
Current: $431.87
Upside: +6.51%
Tempus AI
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $70.93
Upside: +12.79%
CVRx, Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $13 → $5
Current: $1.58
Upside: +216.46%
NeuroPace
Aug 17, 2026
Reiterated: Buy
Price Target: $21
Current: $12.67
Upside: +65.75%
Surgery Partners
Aug 10, 2026
Reiterated: Buy
Price Target: $33 → $18
Current: $13.89
Upside: +29.59%
Progyny
Aug 6, 2026
Reiterated: Buy
Price Target: $31
Current: $27.93
Upside: +10.99%
LifeMD
Aug 5, 2026
Reiterated: Buy
Price Target: $15
Current: $2.63
Upside: +470.34%
Acadia Healthcare Company
Jul 29, 2026
Reiterated: Hold
Price Target: $30
Current: $29.25
Upside: +2.56%
Teladoc Health
Jul 29, 2026
Reiterated: Buy
Price Target: $10
Current: $5.77
Upside: +73.31%
Centene
Jul 28, 2026
Reiterated: Buy
Price Target: $75
Current: $65.36
Upside: +14.75%
Jul 28, 2026
Reiterated: Hold
Price Target: $194
Current: $177.35
Upside: +9.39%
Jul 23, 2026
Reiterated: Hold
Price Target: $209
Current: $196.93
Upside: +6.13%
Jul 23, 2026
Reiterated: Buy
Price Target: $245
Current: $263.78
Upside: -7.12%
Jul 14, 2026
Reiterated: Buy
Price Target: $525
Current: $451.09
Upside: +16.38%
Jul 7, 2026
Reiterated: Buy
Price Target: $95 → $110
Current: $86.16
Upside: +27.67%
Jul 7, 2026
Reiterated: Buy
Price Target: $400 → $450
Current: $412.70
Upside: +9.04%
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $0.3382
Upside: +787.05%
May 8, 2026
Reiterated: Hold
Price Target: $3
Current: $1.77
Upside: +69.49%
Apr 30, 2026
Reiterated: Buy
Price Target: $365 → $340
Current: $282.43
Upside: +20.38%
Apr 20, 2026
Reiterated: Buy
Price Target: $7
Current: $0.5378
Upside: +1,201.60%
Feb 15, 2026
Reiterated: Buy
Price Target: $8
Current: $4.67
Upside: +71.31%
Jan 28, 2026
Reiterated: Buy
Price Target: $440
Current: $379.30
Upside: +16.00%
Jun 13, 2025
Reiterated: Buy
Price Target: $33 → $28
Current: $19.78
Upside: n/a
Sep 15, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $9.10
Upside: n/a
Aug 19, 2022
Reiterated: Buy
Price Target: $7 → $5
Current: $12.25
Upside: n/a
Aug 16, 2022
Reiterated: Hold
Price Target: $128 → $103
Current: $179.25
Upside: n/a
Aug 5, 2022
Reiterated: Hold
Price Target: $50 → $57
Current: $37.55
Upside: n/a
Nov 23, 2020
Upgraded: Buy
Price Target: $56 → $76
Current: $123.33
Upside: n/a
Jun 15, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $0.3579
Upside: n/a
Nov 11, 2019
Reiterated: Buy
Price Target: $96 → $80
Current: $84.01
Upside: n/a
Aug 7, 2019
Reiterated: Sell
Price Target: $4 → $3
Current: $2.76
Upside: n/a
Oct 19, 2017
Reiterated: Hold
Price Target: $290
Current: $423.96
Upside: n/a